Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Diseases and Conditions Researched
What is the purpose of this trial?
This longitudinal randomized trial tests and compares two strategies for improving patient adherence to their oral medication prescriptions.
1. Cancer patients assigned to the intervention will have greater adherence to their prescribed regimen a) at weeks 4 (immediate effect), and be) at weeks 8, and 12 weeks (sustained effect).
2. When compared with patients receiving weekly assessments only, patients receiving weekly assessments plus daily adherence reminders and printed symptom management strategies for 4 weeks will report: lower symptom severity during weeks 2-4 that will be sustained at weeks 5-8, and at 12 weeks.
Click here for detailed participation information for this trial.
|Sponsor:||National Cancer Institute|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.